Caris - Life Science

Main Menu
MENU
  • Patients
    • Fighting Cancer Smarter
      • What is a Biomarker?
    • Patient Stories
    • Find a Physician
    • Share Your Story
    • Financial Services
    • Pay Your Bill
  • Products & Services
    • Molecular Profiling
      • Blood Profiling
      • Tissue Profiling
      • Testing Menu
      • Profiling Technologies
        • Whole Exome (DNA)
          • Homologous Recombination Deficiency
          • Genomic Loss of Heterozygosity
          • Microsatellite Instability
          • Tumor Mutational Burden
          • Human Leukocyte Antigen
        • Whole Transcriptome (RNA)
      • ORDER
    • Artificial Intelligence
      • CODEai
      • FOLFIRSTai
      • GPSai
    • Clinical Trial Solutions
      • Clinical Trials Connector
      • Right in Time
    • Biopharma
      • Discovery
      • Clinical Development
      • Commercialization
      • MI Trials
  • Research
    • Publications
    • R&D Tools
  • Precision Oncology Alliance
    • POA Members
    • POA Leadership
    • POA Working Groups
    • POA Publications
    • POA Newsletter
  • Resources
    • Video Library
    • EHR Integrations
    • Caris Molecular Tumor Board
    • Molecular Minute Podcast
    • Webinars
    • Caris+ App
    • Request Supplies
  • Careers
    • Career Opportunities
    • Benefits
    • Our People
  • About
    • Leadership
    • Newsroom
    • Locations
    • Events
    • Caris Foundation
    • Contact Us

Annual Notice to Physicians 2022

April 26, 2022

Annual Notice to Physicians 2022

Dear Physician/Client:

The Office of the Inspector General (OIG) has issued guidance that recommends laboratories provide notices to physicians and other ordering providers annually as part of their compliance plan. Caris Life Sciences® (Caris) is issuing this notice in accordance with this recommendation. We are committed to conducting business in accordance with all federal, state and local laws, and in adherence with program requirements for all federal, state and private health plans. This letter serves as continuing education for ordering providers on our policies and procedures as they relate to these expectations.

Clinical Consultant

Caris medical staff, including Medical Director Dr. Matthew Oberley, are available to assist with reference testing questions, including ordering and interpretation. Please contact Customer Support at 888-979-8669 or CustomerSupport@CarisLS.com to schedule a consultation.

Test Ordering

Comprehensive tumor profiling from Caris assesses DNA, RNA and Proteins with multiple technologies to reveal a more complete molecular blueprint to guide precise and individualized treatment decisions and improve patient outcomes.

  • MI Profile™ – Multi-platform, solid tumor biomarker analysis. Whole Exome Sequencing (DNA) and Whole Transcriptome Sequencing (RNA), including molecular signature analysis of LOH, MSI, and TMB, as well as HLA Genotyping, pyro sequencing, IHC, and in situ hybridization. Caris FOLFIRSTai™ will be performed for mCRC cases.
  • MI Tumor Seek™ – NGS analysis. Whole Exome Sequencing (DNA) and Whole Transcriptome Sequencing (RNA). Includes molecular signature analysis of LOH, MSI, and TMB, as well as HLA Genotyping. Caris FOLFIRSTai will be performed for mCRC cases. Additional Immuno-Oncology IHC biomarkers can be added: PD-L1 and MMR (MLH1, MSH2, MSH6, PMS2).
  • Caris GPSai™ – Cancer type similarity assessment consisting of algorithmic analyses of the genomic (DNA) and transcriptomic (RNA) characteristics of the tumor as compared to more than 20 distinct tumor types in the Caris database. Only available if MI Profile or MI Tumor Seek is ordered.

In certain localities, a given Caris test may not be approved1. If the test is ordered in those regions, Caris may change the order to a version that is approved (if available), which may include some features ordered by the provider. Alternatively, Caris may cancel the ordered test and the ordering provider will be notified.

Reflex Laboratory Tests

Based on the submitted sample and after initial assessment, reflex testing may be automatically performed for limited tissue cases, and separately billed. Further information about Caris reflex testing can be found on the Caris website (www.CarisLifeSciences.com).

Caris Reporting

The Caris report aligns the molecular profile of the patient’s tumor to a list of relevant therapeutic agents associated with potential benefit or potential lack of benefit. The report is designed to provide the key biomarker and therapeutic information in an easy to interpret front page, with details of all testing performed and references supporting the therapeutic association provided later in the report. After testing, the Caris report can be delivered via the practice’s EMR, fax, email (MI Portal credentials required), Caris+ App or MI Portal.

Medical Necessity

Medicare pays for services that are reasonable and necessary and meet specified Medicare coverage criteria for the beneficiary’s unique medical condition.

As a participating Medicare provider, Caris has the responsibility to make good faith efforts to ensure that all tests requested are performed and billed in a manner that is consistent with federal and state statutes and regulations. The OIG takes the position that ordering providers authorized by law to order clinical laboratory tests for Medicare beneficiaries share the burden of ensuring that only medically necessary services are ordered and billed to Federally funded programs. Providers who submit false claims may be subject to sanctions or remedies available under civil and administrative law.

The Caris Test Requisition Form (TRF) includes a comprehensive set of attestations to determine the coverage status for Medicare services. Completion of the “Relevant Clinical History” section of the TRF enables appropriate determination of coverage for rendered services.

Laboratory claims submitted for services will only be paid if the service is covered, reasonable, and necessary for the beneficiary, given his or her clinical condition, as defined by CMS.

Advance Beneficiary Notice (ABN)

Medicare will only pay for Part B Laboratory services that are determined to be reasonable and necessary. We may need to obtain an Advance Beneficiary Notice (ABN) and/or provide a Notice of Non-Coverage to a beneficiary/patient in advance of what is believed to be a non-covered laboratory service (as determined by the Centers for Medicare and Medicaid Services (CMS) guidelines and/or the fiscal intermediary, and/or other third-party payers).

Medicare Reimbursement Fee Schedule

Medicare reimburses laboratory services based upon a published fee schedule. Medicaid FFS programs typically reimburse based on a fee schedule and the reimbursement is typically equal to or less than the amount Medicare reimburses.

Medicare Coverage Determinations

Services rendered by Caris Life Sciences are typically documented in either Local Coverage Determinations (LCDs) or National Coverage Determinations (NCDs). LCDs and NCDs have sections describing what medical conditions are covered and the ICD-10 codes that are covered. All clinical orders sent to Caris must include at least one ICD-10 code and should include all appropriate ICD-10 codes which describe the patient’s unique medical condition.

Prohibited Referrals and Inducements

It is the policy of Caris to comply with both the Physician Self-Referral Law (Stark) and the Anti-Kickback Statute. If a financial relationship exists between a physician (or their immediate family member) and a laboratory, the Stark Law prohibits the physician from referring Medicare beneficiaries to the laboratory, and the laboratory cannot bill Medicare for any services referred by the physician unless the financial relationship between the parties falls into one of the law’s exceptions. The Anti-Kickback Statute prohibits the knowing or willful offer, payment, solicitation, or receipt of remuneration in order to induce business reimbursed under the Medicare or Medicaid programs. Any form of kickback or inducement to secure Medicare or Medicaid referrals is strictly prohibited.

Patient Privacy

Under the Health Insurance Portability and Accountability Act (HIPAA), Caris is a healthcare provider and a covered entity. We are committed to compliance with all HIPAA privacy and security standards. A copy of our Notice of Privacy Practices is available at www.CarisLifeSciences.com/privacy-us.

Thank you for your time and attention to these important concepts. If you have any questions or require any further information, please contact me directly at 866-771-8946.

Thank you,

Ginger Appleberry
SVP, Chief Compliance Officer and Deputy General Counsel
Caris Life Sciences

Annual Notice to Physicians 2022 PDF

1. Caris FOLFIRSTai, Caris GPSai, HLA Genotype, etc.

Expertise
  • Molecular Profiling
  • Artificial Intelligence
  • Publications
  • Precision Oncology Alliance
  • Clinical Trial Solutions
  • Biopharma
  • Caris Molecular Tumor Board
  • Molecular Minute Podcast
Resources
  • Order
  • Pay Your Bill
  • Find a Physician
  • MI Portal
  • Request Supplies
  • Laboratory Accreditations & Licenses
  • Investigator Studies Program
  • International Distributors
connect
  • Contact Us
  • Careers
  • Leadership
  • Locations
  • Newsroom
  • Video Library
  • Events
follow us
  • Privacy & Website Policies
  • Terms & Conditions
  • Annual Notice to Physicians
© 2023 Caris Life Sciences. All rights reserved.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept,” you consent to the use of all cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT